Welcome to your September issue of The Pipeline from Precision for Medicine, featuring a new white paper, articles, and on-demand content—including the development of at-home tests for COVID-19, insights into successful tissue cross reactivity (TCR) studies, a new partnership to accelerate and diversify trial recruitment, and more.

We hope you’ll find this information valuable as you conquer the complexity inherent to R&D innovation.

The Pipeline features timely insights from our experts in the lab, clinical trials, and data science, designed to help innovative researchers unwind complexity. It is published by Precision for Medicine.

Amanda Woodrooffe, PhD SVP UK Labs
Rebecca Houliston, PhD Principal Scientist
Jeff Daniels, MBA, Executive Director of Strategic Marketing
Karen Richards, RAC, SVP In Vitro Diagnostics and Quality Karen

New White Paper: Successfully Conducting Tissue Cross-Reactivity Studies

Assessing tissue cross-reactivity (TCR) is key to helping minimize risk of harm in first-in-human studies for therapeutic antibodies and antibody-like molecules. This insightful paper shares critical considerations to ensure your TCR study generates the requisite robust data to support pre-clinical decision-making and regulatory submissions.

Contact us and let us connect you with the right expert.